Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. scores highest on Earnings (58) and lowest on Price (4). Its PosiPenta is 39.98 out of 100, weaker than most similar companies.
On the Penta Grid this week, Telomir Pharmaceuticals, Inc. is Grid #541 of 837 in the Healthcare sector in United States, and Grid #2,889 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. | 39.98 | 4 | 58 | 55 | 40 | 43 |
| Citius Oncology, Inc. | 41.57 | 29 | 62 | 41 | 31 | 45 |
| LENSAR, Inc. | 48.65 | 34 | 40 | 39 | 76 | 54 |
| Pelthos Therapeutics Inc. | 29.18 | 0 | 37 | 45 | 20 | 44 |
| CareCloud, Inc. | 50.82 | 35 | 87 | 38 | 49 | 45 |
| Acrivon Therapeutics, Inc. | 42.54 | 42 | 32 | 43 | 54 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.96 |
| P/B ratio | 15.36 |
EEarnings
| Trailing EPS | ₹-103.24 |
| Forward EPS | ₹-26.52 |
NNitro
| Price | 99.45 |
| 52-week high | 161.02 |
| 52-week low | 84.11 |
| Fall from 52-week high | 38.2% |
TTorque
| Return on equity (ROE) | -213.10% |
| Debt-to-equity | 0.03 |
AAnchor
| Beta (price swings) | -0.30 |
| Market cap | ₹732 Cr |
| Insider holding | 42.98% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Telomir Pharmaceuticals, Inc.'s PosiPenta score?
Telomir Pharmaceuticals, Inc.'s PosiPenta is 39.98 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Telomir Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Telomir Pharmaceuticals, Inc. is Grid #541 of 837 in the Healthcare sector in United States, and Grid #2,889 of 4,000 in United States.
Which PosiPenta pillar is strongest for Telomir Pharmaceuticals, Inc.?
Earnings (growth), with a score of 58 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Telomir Pharmaceuticals, Inc.?
Price (valuation), with a score of 4 out of 100: much weaker than most similar companies.
Has Telomir Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.13 points, from 35.85 to 39.98.
PositoAI is for research and education only and is not investment advice.